Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008984
Filing Date
2022-05-16
Accepted
2022-05-16 16:40:27
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20220331x10q.htm   iXBRL 10-Q 1076196
2 EX-31.1 albo-20220331xex31d1.htm EX-31.1 10374
3 EX-31.2 albo-20220331xex31d2.htm EX-31.2 10339
4 EX-32.1 albo-20220331xex32d1.htm EX-32.1 10536
  Complete submission text file 0001558370-22-008984.txt   4203323

Data Files

Seq Description Document Type Size
5 EX-101.SCH albo-20220331.xsd EX-101.SCH 34960
6 EX-101.CAL albo-20220331_cal.xml EX-101.CAL 36436
7 EX-101.DEF albo-20220331_def.xml EX-101.DEF 132611
8 EX-101.LAB albo-20220331_lab.xml EX-101.LAB 310562
9 EX-101.PRE albo-20220331_pre.xml EX-101.PRE 227341
50 EXTRACTED XBRL INSTANCE DOCUMENT albo-20220331x10q_htm.xml XML 500410
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 22930120
SIC: 2834 Pharmaceutical Preparations